Research-use-only disclaimer: BPC-157 supplied by PrymaLab is a research-use-only material for in-vitro and non-human laboratory study
These broad biological effects combined with their favorable stability profile position BPC157 as a highly promising therapeutic candidate for severe tissue injury, potentially offering advantages over conventional cytokine-based wound therapies
Youll notice feeling full faster during meals, less interest in snacking, and reduced food cravings
Step 3: Fast, Discreet Delivery Your compounded medication, along with all necessary supplies, is shipped discreetly to your home
BPC-157, a gastric pentadecapeptide derived from proteolytic enzyme preparations, and TB-500, a synthetic analogue of thymosin beta-4, represent emerging agents with broad biological activity relevant to tissue repair and cytoprotection
For skeletal muscle, heart, or corneal models, TB-500 has stronger coverage with several independent teams (Spurney 2010, Bock-Marquette 2004, Sosne 2011)